Cardiomyopathy in children with mitochondrial disease: Prognosis and genetic background
Cardiomyopathy in children with mitochondrial disease: Prognosis and genetic background
复制标题
DOI:
10.1016/j.ijcard.2019.01.017
复制
发表时间:
2019-03-15
影响因子:
3.5
通讯作者:
Okazaki, Yasushi
中科院分区:
文献类型:
--
作者:
Imai-Okazaki, Atsuko;Kishita, Yoshihito;Okazaki, Yasushi
Background: Cardiomyopathy is a reported indicator of poor prognosis in children with mitochondria' disease. However, the association between prognosis and the genetic background of cardiomyopathy in children with mitochondria' disease has yet to be fully elucidated.Methods and results: Of 137 children with mitochondria' disease whose genetic diagnosis was made between 2004 and 2018,29 had mitochondrial cardiomyopathy (21%). After a median follow-up of 35 months, the overall survival rate was significantly lower in patients with cardiomyopathy than in those without (p < 0001), Ten-year Kaplan-Meier estimates of overall survival were 18 and 67%, respectively. Among the 21 cardiomyopathy patients who died, two died within one month of birth (COQ4 in one patient, and COXIO in one patient), ten died within one year (BOLA3 in three patients, QRSLI in two patients, large chromosomal deletions in two patients, MT-ATP6/8 in one patient, MT-111 in one patient, and TAZ gene in one patient), and nine died after one year (MT-ND5 in three patients, MT-111 in three patients, ACAD9 in one patient, KARS in one patient, and MT-TV in one patient). In the three patients with mitochondrial DNA mutations whose cardiac tissues were available, high heteroplasmy rates in the cardiac tissue were observed for m8528T---C (90%, died at 2 months of age) and m.3243A---G (90 and 80%, died at 12 and 13 years of age, respectively).Conclusions: In children with mitochondrial disease, cardiomyopathy was common (21%) and was associated with increase(' mortality. Genetic analysis coupled with detailed phenotyping could be useful for prognosis. (C) 2019 Published by Elsevier B.V.